Funding Resources
Funding Overview
Funding Strategy
Funding Opportunities |
Research
Anticonvulsant Screening
Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
(TBI) Research
Technology Transfer
Office
NINDS is part of the
National Institutes of
Health
Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transition by registering with Grants.gov and NIH eRA Commons now. |
Sarcoidosis: Research into the Cause of Multi-organ Disease and Clinical Strategies for Therapy (R01)
Release Date: January 20, 2006
Announcement Number: PA-06-123
Application Receipt Date:
February 1, 2006
June 1, 2006
October 1, 2006
Funding Contact: NINDS Funding
Program Area: Neural Environment
Also See:
http://grants.nih.gov/grants/guide/pa-files/PA-07-136.html
Brief Description:
The primary objective of this program announcement is to stimulate research on the etiology and management of sarcoidosis,
a human disorder of granulomatous inflammation. We encourage research that seeks to identify not only the cause of sarcoidosis,
but seeks related predisposing factors, such as genomic, proteomic, metabolomic, lipidomic or glycomic factors related to
the etiology of sarcoidosis. Investigations might include how sarcoidosis perturbs the innate and acquired immunity systems;
affects multi-organs within the human body; and impacts biobehavioral and psychosocial factors of the individual, family,
and community. The goal is to delineate possible causes and phenotypic host characteristics in susceptible or at risk people
so that preventive strategies can be developed, early diagnosis improved, and better antidotes or therapy devised to lessen
initial disease immunopathology. Interventions that are cost effective and reduce the individual, family, and community burden
of the disease are also encouraged. Also, there is interest for approaches to risk reduction, psychological coping, and management
of complications or side effects of treatment.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |